Diverse roles of Primary Health Care in COVID-19 vaccination across 28 European countries - Insights from the Eurodata study.


Journal

The European journal of general practice
ISSN: 1751-1402
Titre abrégé: Eur J Gen Pract
Pays: England
ID NLM: 9513566

Informations de publication

Date de publication:
Dec 2024
Historique:
medline: 22 10 2024
pubmed: 22 10 2024
entrez: 22 10 2024
Statut: ppublish

Résumé

The COVID-19 vaccination campaign in several European countries involved collaboration between public health and Primary Health Care (PHC). To highlight the role of PHC professionals in the COVID-19 vaccination rollout, specifically in terms of vaccine administration, communication and contributing to vaccination population coverage. A descriptive retrospective study of the COVID-19 vaccination campaign across 28 European countries was conducted, covering data from December 2020 to November 2021. Data were collected by key informants recruited from each country, who were health professionals involved in their national vaccination campaigns. Utilising an ad-hoc semi-structured questionnaire, information was gathered on organisation, communication strategies, priority groups, vaccine types, and vaccination pathways in PHC. PHC participated in communication strategies in 10 out of 28 countries, and vaccination was voluntary in most of them. The priority groups for vaccination varied across Europe, and the availability of vaccines in PHC differed between countries within the European Union (EU) and non-EU countries. The BioNTech Pfizer vaccine was the most widely available vaccine in most countries, followed by Moderna and AstraZeneca. PHC administered COVID-19 vaccines to the population, being the nurses the most involved, followed by general practitioners. Vaccination appointments were available online in 18/28 or by phone in 15/28, direct appointments at health centres were available in 8/28. In several countries, healthcare professionals who administered vaccines were given extra compensation for their role. PHC professionals played a crucial role in the successful distribution and administration of COVID-19 vaccines in European countries. Primary Health Care (PHC) professionals, especially nurses and General Practitioners, played a pivotal role in the effective distribution and administration of COVID-19 vaccines in Europe.PHC participated in communication strategies in some countries.Disparities in vaccine availability and prioritisation groups were found across Europe.

Sections du résumé

BACKGROUND UNASSIGNED
The COVID-19 vaccination campaign in several European countries involved collaboration between public health and Primary Health Care (PHC).
OBJECTIVE UNASSIGNED
To highlight the role of PHC professionals in the COVID-19 vaccination rollout, specifically in terms of vaccine administration, communication and contributing to vaccination population coverage.
METHODS UNASSIGNED
A descriptive retrospective study of the COVID-19 vaccination campaign across 28 European countries was conducted, covering data from December 2020 to November 2021. Data were collected by key informants recruited from each country, who were health professionals involved in their national vaccination campaigns. Utilising an ad-hoc semi-structured questionnaire, information was gathered on organisation, communication strategies, priority groups, vaccine types, and vaccination pathways in PHC.
RESULTS UNASSIGNED
PHC participated in communication strategies in 10 out of 28 countries, and vaccination was voluntary in most of them. The priority groups for vaccination varied across Europe, and the availability of vaccines in PHC differed between countries within the European Union (EU) and non-EU countries. The BioNTech Pfizer vaccine was the most widely available vaccine in most countries, followed by Moderna and AstraZeneca. PHC administered COVID-19 vaccines to the population, being the nurses the most involved, followed by general practitioners. Vaccination appointments were available online in 18/28 or by phone in 15/28, direct appointments at health centres were available in 8/28. In several countries, healthcare professionals who administered vaccines were given extra compensation for their role.
CONCLUSION UNASSIGNED
PHC professionals played a crucial role in the successful distribution and administration of COVID-19 vaccines in European countries.
Primary Health Care (PHC) professionals, especially nurses and General Practitioners, played a pivotal role in the effective distribution and administration of COVID-19 vaccines in Europe.PHC participated in communication strategies in some countries.Disparities in vaccine availability and prioritisation groups were found across Europe.

Autres résumés

Type: plain-language-summary (eng)
Primary Health Care (PHC) professionals, especially nurses and General Practitioners, played a pivotal role in the effective distribution and administration of COVID-19 vaccines in Europe.PHC participated in communication strategies in some countries.Disparities in vaccine availability and prioritisation groups were found across Europe.

Identifiants

pubmed: 39435869
doi: 10.1080/13814788.2024.2409240
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2409240

Auteurs

Marina Guisado-Clavero (M)

Investigation Support Multidisciplinary Unit for Primary care in Madrid, Gerencia Asistencial Atención Primaria, Servicio Madrileño de Salud, Madrid, Spain.

Raquel Gómez-Bravo (R)

CHNP, Rehaklinik, Ettelbruck, Luxembourg.
Research Group Self-Regulation and Health, Institute for Health and Behaviour, Department of Behavioural and Cognitive Sciences, Faculty of Humanities, Education, and Social Sciences, Luxembourg University, Luxembourg.

Ileana Gefaell Larrondo (I)

Fundación de Investigación e Innovación Biosanitaria de Atención Primaria (FIIBAP). Research Network on Chronicity, Primary Care and Health Promotion -RICAPPS-(RICORS), Madrid, Spain.

Lourdes Ramos Del Rio (L)

Federica Montseny Health Centre, Gerencia Asistencial de Atención Primaria, Servicio Madrileño de Salud, Madrid, Spain.

Louise Fitzgerald (L)

Member of Irish College of General Practice (MICGP), Member of Royal College of Physician (MRCSI), Dublin, Ireland.

Shlomo Vinker (S)

Department of Family Medicine, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Bert Vaes (B)

Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.

Georgi Tsigarovski (G)

Department of Urology and General Practice, Faculty of Medicine, Medical University of Plovdiv, Plovdiv, Bulgaria.

Péter Torzsa (P)

Department of Family Medicine, Semmelweis University, Budapest, Hungary.

Gunta Ticmane (G)

Department of Family Medicine, Riga Stradiņš University, Riga, Latvia.

Theresa Sentker (T)

Center for Public Health and Healthcare, Hannover Medical School, Hannover, Germany.

Alice Serafini (A)

Azienda Unità Sanitaria Locale di Modena, Laboratorio EduCare, University of Modena and Reggio Emilia, Modena, Italy.

Martin Sattler (M)

European Parliament, Kirchberg, Luxembourg.

Sven Streit (S)

Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.

Goranka Petricek (G)

Department of Family Medicine 'Andrija Stampar' School of Public Health, School of Medicine, University of Zagreb, Croatia, Health Centre Zagreb West, Zagreb, Croatia.

Ferdinando Petrazzuoli (F)

Department of Clinical Sciences in Malmö, Centre for Primary Health Care Research, Lund University, Malmö, Sweden.

Davorina Petek (D)

Department of Family Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Ábel Perjés (Á)

Department of Family Medicine, Semmelweis University, Budapest, Hungary.

Nagu Penakacherla (N)

Kingsbury Road Surgery, Birmingham, United Kingdom.

Oliver Senn (O)

Institute of Primary Care, University of Zurich and University Hospital Zurich, Zurich, Switzerland.

Ana Luisa Neves (AL)

Imperial College London, London, United Kingdom.
Faculty of Medicine of University of Porto, Porto, Portugal.

Katarzyna Nessler (K)

Department of Family Medicine, UJCM at Uniwersytet Jagielloński - Collegium Medicum, Kraków, Poland.

Liubovė Murauskienė (L)

Department of Public Health, Institute of Health Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

Jöel Mossong (J)

Health Directorate, Ministry of Health, Luxembourg City, Luxembourg.

Liga Kozlovska (L)

Department of Family Medicine, Riga Stradins University, Riga, Latvia.

Anna Segernäs (A)

Primary Health Care Centre Ekholmen and Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.

Anna Krztoń-Królewiecka (A)

Department of Family Medicine, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland.

Milena Kostić (M)

Health Center 'Dr Đorđe Kovačević', Lazarevac, Belgrade, Serbia.

Erva Kırkoç Üçüncü (E)

Department of Family Medicine, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey.

Büsra Çimen Korkmaz (B)

Van Gürpınar District Public Hospital, Van Gürpınar, Turkey.

Snežana Knežević (S)

Health Center Kraljevo, Kraljevo, Serbia.

Marijana Jandrić-Kočić (M)

Health Center Krupa na Uni, Republic of Srpska, Bosnia and Herzegovina.

Lisa Kastbom (L)

Primary Health Care Centre Ekholmen and Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.

Ivanna Shushman (I)

Department of Family Medicine and Outpatient Care, UZHNU, Uzhhorod, Ukraine.

Oxana Ilkov (O)

Department of Family Medicine and Outpatient Care, UZHNU, Uzhhorod, Ukraine.

Kathryn Hoffmann (K)

Department of Primary Care Medicine, Med. University of Vienna, Vienna, Austria.

Bruno Heleno (B)

Comprehensive Health Research Center, NOVA Medical School, Universidade Nova de Lisboa, USF das Conchas, Regional Health Administration Lisbon and Tagus Valley, Lisbon, Portugal.

Miroslav Hanževački (M)

Department of Family Medicine 'Andrija Stampar' School of Public Health, School of Medicine, University of Zagreb, Croatia, Health Centre Zagreb West, Zagreb, Croatia.

Dragan Gjorgjievski (D)

Specialist of Family Medicine, Center for Family Medicine, Medical Faculty Skopje, Skopje, North Macedonia.

Sabine Feldman (S)

Department of Family Medicine, Rīga Stradins University, Riga, Latvia.

Philippe-Richard Domeyer (PR)

School of Social Sciences, Hellenic Open University, Patra, Greece.

Maryher Delphin Peña (M)

Department of Geriatric Medicine, Hôpitaux Robert Schuman, Luxembourg City, Luxembourg.

Asja Ćosić Divjak (A)

Health Centre Zagreb Centar, Zagreb, Croatia.

Iliana-Carmen Busneag (IC)

'Spiru Haret' University, Bucharest, Romania.

Elena Brutskaya-Stempkovskaya (E)

General Medicine Department, Belarusian State Medical University, Minsk, Belarus.

Sherihane Bensemmane (S)

Health Services Research, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Sabine Bayen (S)

Department of General Practice, University of Lille, Lille, France.

Maria Bakola (M)

Research Unit for General Medicine and Primary Health Care, Faculty of Medicine, School of Health Science, University of Ioannina, Ioannina, Greece.

Limor Adler (L)

Department of Family Medicine, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Radost Assenova (R)

Department Urology and General Practice, Medical University of Plovdiv, Faculty of Medicine, Plovdiv, Bulgary.

Sara Ares-Blanco (S)

Fundación de Investigación e Innovación Biosanitaria de Atención Primaria (FIIBAP). Research Network on Chronicity, Primary Care and Health Promotion -RICAPPS-(RICORS), Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.

María Pilar Astier-Peña (MP)

Universitas Health Centre, Zaragoza, Spain.
Public Health Service of Aragon, Zaragoza, Spain.
Patient Safety Working Party of semFYC (Spanish Society for Family and Community Medicine) and Quality and Safety in Family Medicine of WONCA World, Barcelona, Spain.
WONCA World and SECA (Spanish Society for Healthcare Quality), Barcelona, Spain.

Heidrun Lingner (H)

Hannover Medical School, Centre for Public Healthcare, Hannover, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH